Literature DB >> 20033346

Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.

Gail A Cresci1, Muthusamy Thangaraju, John D Mellinger, Kebin Liu, Vadivel Ganapathy.   

Abstract

INTRODUCTION: Butyrate is a bacterial fermentation product that produces its beneficial effects on colon through GPR109A, a butyrate receptor, and SLC5A8, a butyrate transporter. In this study, we compared the expression of GPR109A and SLC5A8 between conventional mice and germ-free mice to test the hypothesis that the expression of these two proteins will be decreased in germ-free mice compared to conventional mice because of the absence of bacterial fermentation products and that colonization of germ-free mouse colon with conventional bacteria will reverse these changes.
METHODS: RNA was prepared from the ileum and colon of conventional mice and germ-free mice and used for RT-PCR to determine mRNA levels. Tissue sections were used for immunohistochemical analysis to monitor the expression of GPR109A and SLC5A8 at the protein level. cDNA microarray was used to determine the differential expression of the genes in the colon between conventional mice and germ-free mice.
RESULTS: In conventional mice with normal bacterial colonization of the intestinal tract, GPR109A and SLC5A8 are expressed on the apical membrane of epithelial cells lining the ileum and colon. In germ-free mice, the expression of GPR109A and SLC5A8 is reduced markedly in the ileum and colon. The expression returns to normal levels when the intestinal tract of germ-free mice is colonized with bacteria. The expression of the Na(+)-coupled glucose transporter, SGLT1, follows a similar pattern. Microarray analysis identifies approximately 700 genes whose expression is altered more than twofold in germ-free mice compared to conventional mice. Among these genes are the chloride/bicarbonate exchanger SLC26A3 and the water channel aquaporin 4. The expression of SLC26A3 and AQP4 in ileum and colon is reduced in germ-free mice, but the levels return to normal upon bacterial colonization.
CONCLUSION: Gut bacteria play an active role in the control of gene expression in the host intestinal tract, promoting the expression of the genes that are obligatory for the biological actions of the bacterial fermentation product butyrate and also the genes that are related to electrolyte and water absorption.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033346     DOI: 10.1007/s11605-009-1045-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  34 in total

1.  Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids.

Authors:  Seiji Miyauchi; Elangovan Gopal; You-Jun Fei; Vadivel Ganapathy
Journal:  J Biol Chem       Date:  2004-02-13       Impact factor: 5.157

Review 2.  Short-chain fatty acids: ready for prime time?

Authors:  Claude C Roy; C Lawrence Kien; Lise Bouthillier; Emile Levy
Journal:  Nutr Clin Pract       Date:  2006-08       Impact factor: 3.080

Review 3.  Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.

Authors:  P B Mortensen; M R Clausen
Journal:  Scand J Gastroenterol Suppl       Date:  1996

4.  SCFAs: The Enigma of Weak Electrolyte Transport in the Colon.

Authors:  Joseph H. Sellin
Journal:  News Physiol Sci       Date:  1999-04

Review 5.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

6.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 7.  How host-microbial interactions shape the nutrient environment of the mammalian intestine.

Authors:  Lora V Hooper; Tore Midtvedt; Jeffrey I Gordon
Journal:  Annu Rev Nutr       Date:  2002-04-04       Impact factor: 11.848

8.  Angiogenins: a new class of microbicidal proteins involved in innate immunity.

Authors:  Lora V Hooper; Thaddeus S Stappenbeck; Chieu V Hong; Jeffrey I Gordon
Journal:  Nat Immunol       Date:  2003-01-27       Impact factor: 25.606

Review 9.  Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk?

Authors:  Michael Bordonaro; Darina L Lazarova; Alan C Sartorelli
Journal:  Cell Cycle       Date:  2008-02-26       Impact factor: 4.534

10.  PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.

Authors:  Sorin Tunaru; Jukka Kero; Annette Schaub; Christian Wufka; Andree Blaukat; Klaus Pfeffer; Stefan Offermanns
Journal:  Nat Med       Date:  2003-02-03       Impact factor: 53.440

View more
  60 in total

1.  Characterization of butyrate uptake by nontransformed intestinal epithelial cell lines.

Authors:  Pedro Gonçalves; João R Araújo; Fátima Martel
Journal:  J Membr Biol       Date:  2011-02-01       Impact factor: 1.843

Review 2.  Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice.

Authors:  Michael Fenech; Ahmed El-Sohemy; Leah Cahill; Lynnette R Ferguson; Tapaeru-Ariki C French; E Shyong Tai; John Milner; Woon-Puay Koh; Lin Xie; Michelle Zucker; Michael Buckley; Leah Cosgrove; Trevor Lockett; Kim Y C Fung; Richard Head
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-05-28

Review 3.  Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Authors:  Medha Priyadarshini; Kumar U Kotlo; Pradeep K Dudeja; Brian T Layden
Journal:  Compr Physiol       Date:  2018-06-18       Impact factor: 9.090

4.  GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.

Authors:  Deeksha Gambhir; Sudha Ananth; Rajalakshmi Veeranan-Karmegam; Selvakumar Elangovan; Shanterian Hester; Eric Jennings; Stefan Offermanns; Julian J Nussbaum; Sylvia B Smith; Muthusamy Thangaraju; Vadivel Ganapathy; Pamela M Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

5.  The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function.

Authors:  Veena Coothankandaswamy; Selvakumar Elangovan; Nagendra Singh; Puttur D Prasad; Muthusamy Thangaraju; Vadivel Ganapathy
Journal:  Biochem J       Date:  2013-02-15       Impact factor: 3.857

Review 6.  Brain-gut microbiome interactions and functional bowel disorders.

Authors:  Emeran A Mayer; Tor Savidge; Robert J Shulman
Journal:  Gastroenterology       Date:  2014-02-28       Impact factor: 22.682

Review 7.  Gut Microbiome and Bone: to Build, Destroy, or Both?

Authors:  Jing Yan; Julia F Charles
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

8.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.

Authors:  Nagendra Singh; Ashish Gurav; Sathish Sivaprakasam; Evan Brady; Ravi Padia; Huidong Shi; Muthusamy Thangaraju; Puttur D Prasad; Santhakumar Manicassamy; David H Munn; Jeffrey R Lee; Stefan Offermanns; Vadivel Ganapathy
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

9.  Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats.

Authors:  Françoise Rul; Leila Ben-Yahia; Fatima Chegdani; Laura Wrzosek; Stéphane Thomas; Marie-Louise Noordine; Christophe Gitton; Claire Cherbuy; Philippe Langella; Muriel Thomas
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

Review 10.  Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.

Authors:  Bojana Ristic; Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-05-13       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.